Pharmacytimes: Condition Center: ADHD http://www.pharmacytimes.com/condition-resources/adhd/condition-rss ADHD en-us Sat, 10 Dec 2016 02:37:21 UTC Sat, 10 Dec 2016 02:37:21 UTC Generic Dexedrine from Mylan Now Available http://www.pharmacytimes.com/product-news/generic-dexedrine-from-mylan-now-available Mylan’s generic version of Dexedrine is now available at US pharmacies in 3 dosage strengths. 7:00 AM, Mon August 8, 2016 2 Chronic Health Conditions on the Rise Among Children http://www.pharmacytimes.com/news/2-chronic-health-conditions-on-the-rise-among-children Chronic health conditions are on the rise among children, especially those living in poverty. 11:00 PM, Mon May 30, 2016 5 Things to Know About Adult ADHD http://www.pharmacytimes.com/news/5-things-to-know-about-adult-adhd Attention-deficit/hyperactivity disorder has long been viewed as a pediatric condition, but it often lasts into adulthood. 9:52 PM, Tue February 2, 2016 Pregnant Women on Antidepressants Need Not Fear ADHD, Autism Risk http://www.pharmacytimes.com/resource-centers/womens-health/pregnant-women-on-antidepressants-need-not-fear-adhd-autism-risk Exposure to antidepressants during pregnancy does not impact a baby’s risk for autism or attention-deficit/hyperactivity disorder after birth. 10:00 PM, Mon January 18, 2016 10 Surprising Off-Label Uses for Prescription Medications http://www.pharmacytimes.com/contributor/timothy-o-shea/2016/01/10-surprising-off-label-uses-for-prescription-medications How many of these off-label uses have you seen before? 4:01 AM, Tue January 5, 2016 Chewable ADHD Treatment Approved by FDA http://www.pharmacytimes.com/product-news/chewable-adhd-treatment-approved-by-fda The FDA has approved Pfizer's chewable formulation of methylphenidate HCl (QuilliChew ER) for the treatment of ADHD in patients 6 years and older. 10:01 PM, Mon December 7, 2015 Mylan Launches Generic Adderall http://www.pharmacytimes.com/product-news/mylan-launches-generic-adderall Mylan has launched a generic version of Teva Pharmaceuticals' Adderall in 5 mg, 7.5 mg, 10 mg, 12.5 mg, 20 mg, and 30 mg doses. 6:00 AM, Wed November 25, 2015 FDA Approves Liquid ADHD Treatment for Kids http://www.pharmacytimes.com/product-news/fda-approves-liquid-adhd-treatment-for-kids The FDA today approved Tris Pharma's extended-release amphetamine oral suspension (Dyanavel XR) for the treatment of ADHD in children aged 6 years and older. 5:07 AM, Tue October 20, 2015 Antipsychotics Prescribed to Boys More Often Than Girls http://www.pharmacytimes.com/news/antipsychotics-prescribed-to-boys-more-often-than-girls Young male patients tend to receive antipsychotic prescriptions more often than their female counterparts. 9:00 PM, Wed July 15, 2015 Permanent Skin Color Loss Seen with Daytrana ADHD Patch http://www.pharmacytimes.com/product-news/Permanent-Skin-Color-Loss-Seen-with-Daytrana-ADHD-Patch The FDA has added a new warning to the drug label of the methylphenidate transdermal system indicated for ADHD to describe permanent loss of skin color, also known as chemical leukoderma. 3:25 AM, Wed June 24, 2015 Adult ADHD Prescriptions Surpass Pediatric Use http://www.pharmacytimes.com/news/adult-adhd-prescriptions-surpass-pediatric-use An increasing number of adults receiving prescription stimulant medications challenge the notion that ADHD is a children's condition and create new obstacles for pharmacists. 1:48 AM, Wed June 24, 2015 4 Generic Versions of Intuniv ADHD Drug Launched in US http://www.pharmacytimes.com/product-news/4-Generic-Versions-of-Intuniv-ADHD-Drug-Launched-in-US Four separate drug manufacturers have launched generic versions of Shire's Intuniv ADHD treatment for children aged 6 to 17 years. 9:00 PM, Thu June 4, 2015 FDA Accepts Liquid Amphetamine Application for ADHD http://www.pharmacytimes.com/product-news/FDA-Accepts-Liquid-Amphetamine-Application-for-ADHD The FDA had accepted for review Tris Pharma's New Drug Application for its extended-release liquid amphetamine to treat ADHD in children. 12:14 AM, Tue May 26, 2015 Kids with ADHD at Risk for Eating Disorder http://www.pharmacytimes.com/news/Kids-with-ADHD-at-Risk-for-Eating-Disorder Children with attention-deficit/hyperactivity disorder may be more at risk for binge eating than their peers. 10:00 PM, Mon April 27, 2015 Pediatric Data Needed for Adult ADHD Drug Approval http://www.pharmacytimes.com/product-news/Pediatric-Data-Needed-for-Adult-ADHD-Drug-Approval Even though Shire is seeking an adult indication for its investigational ADHD treatment, the FDA is requesting pediatric data before deliberating the drug's approval. 12:41 AM, Wed April 8, 2015 New ADHD Drug Dosing Option Now Available http://www.pharmacytimes.com/product-news/New-ADHD-Drug-Dosing-Option-Now-Available Shire's ADHD treatment, lisdexamfetamine dimesylate (Vyvanse), is now available in a 10-mg titration dose. 11:00 PM, Mon March 23, 2015 Genetic ADHD Test May Inform More Effective Treatment http://www.pharmacytimes.com/news/Genetic-ADHD-Test-May-Inform-More-Effective-Treatment The new test aids health care professionals and patients in determining whether a specific medication will address ADHD symptoms effectively. 10:51 PM, Tue March 17, 2015 Manic Symptoms May Pass from Bipolar Parent to Child http://www.pharmacytimes.com/resource-centers/bipolar-disorder/Manic-Symptoms-May-Pass-from-Bipolar-Parent-to-Child Children born to parents with bipolar disorder have a strong likelihood of experiencing episodes of manic symptoms themselves. 10:00 PM, Thu March 12, 2015 How to Differentiate Between Bipolar Disorder and ADHD http://www.pharmacytimes.com/resource-centers/bipolar-disorder/How-to-Differentiate-Between-Bipolar-Disorder-and-ADHD Because there are similarities in the symptoms of bipolar disorder and attention-deficit/hyperactivity disorder, differentiating between the 2 psychiatric conditions can be challenging for clinicians. 10:00 PM, Sat February 14, 2015 Adverse Reactions to Methylphenidate ADHD Treatment Aren't Serious http://www.pharmacytimes.com/news/Adverse-Reactions-to-Methylphenidate-ADHD-Treatment-Arent-Serious Although children with attention deficit hyperactivity disorder often experience decreased appetite and sleep disturbances during methylphenidate treatment, a study published in the Journal of Research in Pharmacy Practice indicates that those adverse drug reactions (ADRs) are mostly mild and not serious. 4:00 AM, Sun February 8, 2015